These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 27708234)
1. Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer. Li L; Zhang GQ; Chen H; Zhao ZJ; Chen HZ; Liu H; Wang G; Jia YH; Pan SH; Kong R; Wang YW; Sun B Oncotarget; 2016 Nov; 7(44):71773-71781. PubMed ID: 27708234 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21. Rong H; Chen B; Ma K; Wei X; Peng J; Zhu J Cancer Biother Radiopharm; 2021 Apr; 36(3):273-279. PubMed ID: 32401035 [No Abstract] [Full Text] [Related]
3. Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer. He T; Yuan C; Zhao C Biomed Pharmacother; 2021 Nov; 143():112127. PubMed ID: 34474342 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival. Feng H; Zhang J; Shi Y; Wang L; Zhang C; Wu L J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LINC-PINT as a novel prognostic biomarker in human cancer: a meta-analysis and machine learning. Lin J; Chen L; Zhang D Sci Rep; 2024 Mar; 14(1):7483. PubMed ID: 38553526 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA Duan J; Ma X; Shi J; Xuan Y; Wang H; Li P; Zhang Y; Fan Y; Gong H; Ma X; Pang Y; Wang L; Yan Y; Zhang X Onco Targets Ther; 2019; 12():4729-4740. PubMed ID: 31417274 [No Abstract] [Full Text] [Related]
7. Downregulation of long non-coding RNA LINC-PINT serves as a diagnostic and prognostic biomarker in patients with non-small cell lung cancer. Zhang C; Gong C; Li J; Tang J Oncol Lett; 2021 Mar; 21(3):210. PubMed ID: 33552292 [TBL] [Abstract][Full Text] [Related]
8. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21. Liu W Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482 [No Abstract] [Full Text] [Related]
9. lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR. Huang Q; Zhang D; Diao Q; Lin M Oncol Lett; 2019 Sep; 18(3):2917-2922. PubMed ID: 31452772 [TBL] [Abstract][Full Text] [Related]
10. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer. Zhao T; Wu L; Li X; Dai H; Zhang Z Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis. Yuan Z; Xiu C; Liu D; Zhou G; Yang H; Pei R; Ding C; Cui X; Sun J; Song K J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO. Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453 [TBL] [Abstract][Full Text] [Related]
13. Linc-pint inhibits early stage pancreatic ductal adenocarcinoma growth through TGF-β pathway activation. Lu H; Yang D; Zhang L; Lu S; Ye J; Li M; Hu W Oncol Lett; 2019 May; 17(5):4633-4639. PubMed ID: 30944652 [TBL] [Abstract][Full Text] [Related]
14. Up regulation of long non-coding RNAs BACE1 and down regulation of LINC-PINT are associated with CRC clinicopathological characteristics. Bakhtiari-Nezhad S; Rejali L; Hadizadeh M; Taleghani MY; Aghdaei HA; Young C; Khanabadi B; Nazemalhosseini-Mojarad E; Bonab MA Mol Biol Rep; 2022 Nov; 49(11):10259-10267. PubMed ID: 36087249 [TBL] [Abstract][Full Text] [Related]
15. Role of Long Non-Coding RNA (LncRNA) LINC-PINT Downregulation in Cardiomyopathy and Retinopathy Progression Among Patients with Type 2 Diabetes. Zha T; Su F; Liu X; Yang C; Liu L Med Sci Monit; 2019 Nov; 25():8509-8514. PubMed ID: 31711064 [TBL] [Abstract][Full Text] [Related]
16. PINTology: A short history of the lncRNA LINC-PINT in different diseases. Bukhari I; Khan MR; Hussain MA; Thorne RF; Yu Y; Zhang B; Zheng P; Mi Y Wiley Interdiscip Rev RNA; 2022 Jul; 13(4):e1705. PubMed ID: 35019222 [TBL] [Abstract][Full Text] [Related]
17. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression. Jia M; Li Z; Pan M; Tao M; Wang J; Lu X Mol Ther Nucleic Acids; 2020 Dec; 22():319-328. PubMed ID: 33230437 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LINC-PINT is associated with favorable prognosis in cancer patients: a systematic review and meta-analysis. Han N; Koh HM Transl Cancer Res; 2024 Sep; 13(9):4913-4922. PubMed ID: 39430827 [TBL] [Abstract][Full Text] [Related]
19. LINC-PINT Activates the Mitogen-Activated Protein Kinase Pathway to Promote Acute Myocardial Infarction by Regulating miR-208a-3p. Zhu J; Gu H; Lv X; Yuan C; Ni P; Liu F Circ J; 2018 Oct; 82(11):2783-2792. PubMed ID: 30249926 [TBL] [Abstract][Full Text] [Related]
20. LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint. Hong L; Wang H; Wang J; Wei S; Zhang F; Han J; Liu Y; Ma M; Liu C; Xu Y; Jiang D Cancer Manag Res; 2019; 11():10393-10399. PubMed ID: 31849528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]